Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors

apnews.com

LEXINGTON, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the appointment of Robert Plenge, M.D., Ph.D., vice president, research and early development and head of the Inflammation and Immunology Thematic Center of Excellence Unit at Celgene, to its Board of Directors...

Mentions: Nasdaq Translate Bio Robert Plenge, M.D.